Condition: Coronary Disease · Sponsor: Robocath
The main objective of the CHANGE registry is the evaluation of the real-world performance and safety profile of the R-One System in PCI.
This description comes directly from the study's public registry record.
Hamouda Abassi, PhD · +33 2 32 10 67 42 · hamouda.abassi@robocath.com
Always discuss trial participation with your own doctor first.
| Het Ziekenhuisnetwerk Antwerpen vzw | Antwerp, Belgium | Recruiting |
| Brest university hospital | Brest, Brittany Region, France | Recruiting |
| Rouen university hospital | Rouen, France | Recruiting |
| Centre Cardiologique du Nord | Saint-Denis, Île-de-France Region, France | Recruiting |
| Rheinland Klinikum Neuss GmbH | Neuss, Lukaskrankenhaus, Germany | Recruiting |
| San Donato Policlinco Kardia | San Donato Milanese, MI, Italy | Not Yet Recruiting |
| Polskie Towarzystwo Kardiologiczne | Warsaw, Par Défaut, Poland | Not Yet Recruiting |
| Netcare Christiaan Barnard Memorial Hospital | Cape Town, le Cap, South Africa | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05853419